Experiment 1284018

Worktypes

PHARMACOLOGY OF COMPOUND - IN HUMANSPATENT DESCRIBED

Compounds isolated

GALANTHAMINE

Alerts

SEE ARTICLE FOR OTHER TEST RESULTS.BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.

Details

PropertyValue
Pharmacology
ANTIALZHEIMER'S ACTIVITY
Administration routeORAL
OrganismEmpty organism
CitationPARYS,WLJ: PONTECORVO,M:. (2001). A USE OF GALANTHAMINE FOR THE TREATMENT OF NEUROPSYCHIATRIC BEHAVIOR ASSOCIATED WITH ALZHEIMER'S DISEASE.. 2001()
Amount utilized
Compound isolated
Dose amount16.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE